doi:10.1038/onc.2008.21
Marked improvement in energy, mood, and physical performance
The role of hepatitis B virus surface protein in inducing Sertoli cell ferroptosis
Why it's bad: Humidity accelerates degradation Temperature swings stress the product Moisture can contaminate products Better storage: Bedroom drawer (cool, dry, dark) Refrigerator (best) Climate-controlled closet Mistake 2: Leaving reconstituted injectable at room temp This is the most common and costly mistake
There are currently no FDA-approved GLP-1 patches, and most of whats sold are just supplements or herbal blends, which not the same proven medications found in prescriptions like semaglutide or tirzepatide
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription